Guardian Pharmacy Services (GRDN) Q3 FY2023 earnings: revenue $263 million
Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $263 million for Q3 FY2023, the quarter ended 30 September 2023. Net income was -$7 million. The figures are the company's own, from the 10-Q it filed with the SEC on 12 November 2024.
Revenue$263 million
Net income-$7 million
Diluted EPSn/a
QuarterQ3 FY2023ended 30 September 2023
The quarter, against the one before and a year earlier
| Line | Q3 FY2023 | Quarter before | A year earlier | Change on the year |
|---|---|---|---|---|
| Revenue | 263 | n/a | n/a | n/a |
| Cost of revenue | 211 | n/a | n/a | n/a |
| Gross profit | 52.2 | n/a | n/a | n/a |
| Gross margin | 19.9% | n/a | n/a | |
| Selling, general and administrative | 58.5 | n/a | n/a | n/a |
| Operating income | -6.3 | n/a | n/a | n/a |
| Operating margin | -2.4% | n/a | n/a | |
| Interest expense | 0.7 | n/a | n/a | n/a |
| Pre-tax income | -7.0 | n/a | n/a | n/a |
| Net income | -7.0 | n/a | n/a | n/a |
| Net margin | -2.7% | n/a | n/a |
$ million except per share.
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Balance sheet at quarter end
| Line | Q3 FY2023 | Quarter before | A year earlier | Change on the year |
|---|---|---|---|---|
| Shareholders' equity | 59.7 | n/a | n/a | n/a |
| Cash and equivalents | 0.6 | n/a | n/a | n/a |
Questions
What was Guardian Pharmacy Services' revenue in Q3 FY2023?
Guardian Pharmacy Services (GRDN) reported revenue of $263 million for Q3 FY2023, the quarter ended 30 September 2023.
How much did Guardian Pharmacy Services earn in Q3 FY2023?
Net loss for Q3 FY2023 was $7 million.
When did Guardian Pharmacy Services report Q3 FY2023 results?
Guardian Pharmacy Services filed its 10-Q for the quarter ended 30 September 2023 with the SEC on 12 November 2024.
Quarterly results, the last 11 quarters
| Q3 FY2023 | Q1 FY2024 | Q2 FY2024 | Q3 FY2024 | Q4 FY2024 * | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 * | Q1 FY2026 | Q2 FY2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 263 | 275 | 300 | 314 | 339 | 329 | 344 | 377 | 398 | 337 | 352 |
| Cost of revenue | 211 | 220 | 239 | 254 | 271 | 265 | 276 | 303 | 312 | 260 | 272 |
| Gross profit | 52.2 | 55.1 | 61.3 | 60.9 | 67.1 | 64.3 | 68.1 | 74.7 | 85.5 | 76.3 | 80.0 |
| Gross margin | 20% | 20% | 20% | 19% | 20% | 20% | 20% | 20% | 22% | 23% | 23% |
| SG&A | 58.5 | 47.2 | 44.3 | 165 | 50.3 | 51.3 | 55.6 | 58.4 | 54.7 | 58.6 | 59.4 |
| Operating income | -6.3 | 7.9 | 17.0 | -105 | 16.8 | 13.0 | 12.6 | 16.4 | 30.8 | 17.7 | 20.6 |
| Operating margin | -2% | 3% | 6% | -33% | 5% | 4% | 4% | 4% | 8% | 5% | 6% |
| Interest expense | 0.7 | 0.8 | 1.1 | 1.0 | 0.4 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Pre-tax income | -7.0 | 7.1 | 15.8 | -106 | 16.2 | 13.1 | 12.6 | 16.6 | 31.1 | 18.3 | 29.8 |
| Tax rate | n/a | 0% | 0% | n/a | 27% | 29% | 30% | 42% | 32% | 26% | 26% |
| Net income | -7.0 | 7.1 | 0.0 | -122 | 11.9 | 9.4 | 9.0 | 9.8 | 20.9 | 13.3 | 21.9 |
| Net margin | -3% | 3% | 0% | -39% | 4% | 3% | 3% | 3% | 5% | 4% | 6% |
| Diluted EPS | n/a | n/a | n/a | -$2.00 | $0.19 | $0.15 | $0.14 | $0.15 | $0.33 | $0.21 | $0.34 |
| Operating cash flow | n/a | 8.7 | 29.1 | -2.2 | 22.3 | 17.6 | 19.9 | 28.2 | 34.6 | 6.1 | 30.0 |
| Capital expenditure | n/a | n/a | n/a | 2.2 | n/a | n/a | n/a | 4.0 | n/a | n/a | n/a |
| Free cash flow | n/a | n/a | n/a | -4.4 | n/a | n/a | n/a | 24.2 | n/a | n/a | n/a |
| Shares outstanding | n/a | n/a | n/a | 63m | n/a | 63m | 63m | 63m | 63m | 63m | 63m |
| Filing | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Each quarter as filed, linked to its filing.
Read more
* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.10-Q for the period ended 30 September 2023, filed 12 November 2024: the filing.